Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | JSB PHARMACEUTICALS | 1 | ₹1,722 |
| 2 | Schedule 2 | JSB PHARMACEUTICALS | 1 | ₹550 |
| 3 | Schedule 3 | SUKUN PHARMA | 1 | ₹2,754 |
| 4 | Schedule 4 | SUKUN PHARMA | 1 | ₹366 |
| 5 | Schedule 5 | AARADHYA SURGIMED | 1 | ₹576 |
Tender Value
₹4 L
EMD Value
Exempted
Closing Date
29 Jan 2024, 1:00 pmClosed
Drug and Consumable
5922159
GEM/2024/B/4507652
Two Packet Bid
Amantadine 100 mg Cap,Fluoxetine HCl 20 mg Cap,Sevelamer 800 mg Tab,Tab Dutasteride 0.5 mg and Tams
10 days
Madhya Pradesh; Sagar
Item wise evaluation
BOQ
4 documents required · 4 mandatory
3 yrs
50%
Exempted
29 Jan 2024
19 Jan 2024
29 Jan 2024
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|
| 1 | Amantadine 100 mg Cap | 600 | No | VIJAYk@150 | 10 |
| 2 | Fluoxetine HCl 20 mg Cap | 1,100 | No | VIJAYk@150 | 10 |
| 3 | Sevelamer 800 mg Tab | 600 | No | VIJAYk@150 | 10 |
| 4 | Tab Dutasteride 0.5 mg and Tamsulosin HCl 0.4mg Cap | 600 | No | VIJAYk@150 | 10 |
| 5 | Tab Nitroglycerine 2.6mg | 800 | No | VIJAYk@150 | 10 |
| 6 | Tab Paracetamol 650 mg | 4,400 | No | VIJAYk@150 | 10 |
| 7 | Sodium bicarbonate 0.5 gm Tab | 1,100 | No | VIJAYk@150 | 10 |
| 8 | Voglibose 0.2 mg Tab | 1,300 | No | VIJAYk@150 | 10 |
| 9 | Tab Tenofovir 300 mg | 800 | No | VIJAYk@150 | 10 |
| 10 | Zolpidem 10 mg Tab | 600 | No | VIJAYk@150 | 10 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_5922159.pdf
GEM_BID
gem_bid_13_dglp_2024-01-19-12-50-11_d52abb4d9cf05638b586b46dbbee71f3.pdf
BOQ
boq_item_bid__file_-_dglp_13_-_boq_2024-01-19-12-50-11_844621807892e5ccf3778db491730c77.csv
BOQ
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .